PALO ALTO, Calif.–(BUSINESS WIRE)– #Biotechnology–TCGX Acquisition Corp. II (the “Company”) announced today that it priced its initial public offering of 10,000,000 Class A ordinary shares at a price of $10.00 per share, for gross proceeds of $100,000,000. Unlike certain other special purpose acquisition company initial public offerings, investors in this offering will not receive warrants that would become exercisable following the completion of the Company’s initial business combination.The Class A ordinary
